<?xml version="1.0" encoding="UTF-8"?>
<p id="p0175">To summarize, the application of vaccine adjuvant requires a thorough understanding of the effect of adjuvants on immune response and mechanisms of action. The application of adjuvants in subunit vaccines are listed in 
 <xref rid="tbl3" ref-type="table">Table 3</xref>
 <xref rid="bib83" ref-type="bibr">
  <sup>83</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib85" ref-type="bibr">
  <sup>85</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib87" ref-type="bibr">
  <sup>87</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib88" ref-type="bibr">
  <sup>88</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib91" ref-type="bibr">91</xref>, 
 <xref rid="bib92" ref-type="bibr">92</xref>, 
 <xref rid="bib93" ref-type="bibr">93</xref>, 
 <xref rid="bib94" ref-type="bibr">94</xref>
 <sup>,</sup>
 <xref rid="bib98" ref-type="bibr">98</xref>, 
 <xref rid="bib99" ref-type="bibr">99</xref>, 
 <xref rid="bib100" ref-type="bibr">100</xref>, 
 <xref rid="bib101" ref-type="bibr">101</xref>, 
 <xref rid="bib102" ref-type="bibr">102</xref>, 
 <xref rid="bib103" ref-type="bibr">103</xref>, 
 <xref rid="bib104" ref-type="bibr">104</xref>, 
 <xref rid="bib105" ref-type="bibr">105</xref>, 
 <xref rid="bib106" ref-type="bibr">106</xref>
 <sup>,</sup>
 <xref rid="bib108" ref-type="bibr">
  <sup>108</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib109" ref-type="bibr">
  <sup>109</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib112" ref-type="bibr">
  <sup>112</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib113" ref-type="bibr">
  <sup>113</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib118" ref-type="bibr">
  <sup>118</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib122" ref-type="bibr">
  <sup>122</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib123" ref-type="bibr">
  <sup>123</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib125" ref-type="bibr">
  <sup>125</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib126" ref-type="bibr">
  <sup>126</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib128" ref-type="bibr">
  <sup>128</sup>
 </xref>. In addition to safety considerations, the design of adjuvants must also pay attention to the ability to selectively induce and regulate the types of immune responses in the body, so as to effectively promote the humoral and cellular immunity to combat coronavirus infection. It is also noteworthy to mention that an existing well-established adjuvant could be combined with new immunostimulants (
 <italic>e</italic>.
 <italic>g</italic>., TLRs agonist) to improve the breadth and intensity of the immune responses, which has become a potential strategy for exploring efficient adjuvant systems.
</p>
